Delivery Order SPE2DB22D1017-SPE2DB24FG6BB

Award Date 9/27/24
Potential Completion Date 9/30/24
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PREMARIN 0.45 MG TABLET 100S. The contract has a firm fixed price of $1,142.86 and a period of performance through June 18, 2025. The contract is not designated as a set-aside and is an open competition. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of PREMARIN 0.3 MG TABLET 100S, a pharmaceutical product, with a firm fixed price of $2,440.83 and a completion date of February 23, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,845.24, is for the delivery of PREMARIN 0.625 MG TABLET 100S, a pharmaceutical product. The contract has a firm fixed price pricing type and a period of performance through April 19, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PREMARIN 0.3 mg tablets. The contract has a firm fixed-price, with a ceiling value of $1,552.53 and a completion date of June 11, 2025. This contract is not set aside and represents open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The $2,289.33 contract is for the delivery of PREMARIN 0.3 MG TABLET 1000S, a pharmaceutical product, to be completed by February 23, 2024. The delivery order is issued under a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which has a potential...
This is a $3,347.80 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of PREMARIN 0.625 MG TABLET 100S. The contract has an ultimate completion date of August 16, 2024 and is not set aside for a specific business type. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is providing these prescription medications to support military treatment facilities and other federal healthcare programs. This delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PREMARIN 0.3 MG TABLET 1000S. The fixed-price contract has a ceiling value of $29,708.01 and a performance period ending on May 14, 2025. It is not a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which provides a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,908.08 firm fixed-price contract is for the delivery of PREMARIN 0.45 MG TABLET 100S, a pharmaceutical product, with a completion date of June 18, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,831.44 firm fixed-price delivery order is for the supply of PREMARIN 0.3 MG TABLET 100S and has a contract type of Delivery Order with a period of performance through November 7, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PREMARIN 0.625 MG TABLET 100S. The contract, valued at $1,318.52, has a period of performance through July 22, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG6BB
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PREMARIN 0.3 MG TABLET 1000S. The contract has a firm fixed price of $20,403.44 and a period of performance through September 30, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which allows for the efficient procurement of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/27/24, 9:10 AM